CTRI/2023/05/052664已完成Unknown
A Prospective, Open-Label, Single-Center Study of the Safety and Effectiveness of the AVL200 Modular Intraocular Lens System.
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Visually significant cataract.
- •2)Best corrected distance visual acuity between 20/40 and 20/200.
- •3)Corneal astigmatism <= 1.5 diopters.
- •4)Potential distance visual acuity of 20/25 or better.
排除标准
- •1)Uncontrolled systemic disease that could increase operative risk or confound outcome.
- •2)Use of medication that could affect accommodation.
- •3)Previous corneal surgery or significant corneal abnormalities.
- •3)Ocular pathology or degenerative disorder having potential to impair visual acuity.
- •4)Pupil abnormality.
- •5)Intraoperative cataract surgery complications that could affect IOL implantation or positioning.
研究者
相似试验
已完成
3 期
A Clinical Study To Evaluate The Safety And Efficacy Of Lithobin Tablets In Patients With Renal CalculiCTRI/2022/07/043684Jammi Pharmaceuticals Pvt Ltd
进行中（未招募）
1 期
Study to investigate the effect of riociguat on right heart size and function in pulmonary hypertensioSymptomatic pulmonary arterial hypertension with a mean pulmonary artery pressure >20 mmHg and pulmonary vascular resistance =2 Wood Units, pulmonary arterial wedge pressure =15 mmHg (Group I / Nice Clinical Classification of Pulmonary Hypertension (PH)) or CTEPH (Group IV) with hemodynamics as stated above defined as inoperable measured at least 3 months after start of full anticoagulation or with persisting or recurrent PH after pulmonary endarterectomy at least 6 months after surgeryMedDRA version: 20.0Level: HLTClassification code 10037401Term: Pulmonary hypertensionsSystem Organ Class: 100000004855EUCTR2020-005462-34-DEThoraxklinik Heidelberg gGmbH30
进行中（未招募）
1 期
An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary HypertensioPulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary HypertensionMedDRA version: 20.0Level: HLTClassification code: 10037401Term: Pulmonary hypertensions Class: 10047065CTIS2023-509696-17-00Thoraxklinik Heidelberg gGmbH30
尚未招募
不适用
An Open-Label, Non-Randomized, Single-Center Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients with Advanced Solid Tumors or Lymphomas, who are Unsuitable For, or Have Failed, Existing TherapiesDrug Metabolism10027656CancerNL-OMON33844Eisai10
尚未招募
不适用
An Open-Label, Non-Randomized, Single-Center Study to Determine the Metabolism and Elimination of Carbon-14 labeled Eribulin Acetate (14C-Eribulin) in Patients with Advanced Solid TumorsDrug metabolism10027656CancerNL-OMON32470Eisai10